dalteparin has been researched along with Hemorrhage, Retinal in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of protein S deficiency causing central retinal vein occlusion treated with anticoagulation, which includes heparin followed by oral warfarin therapy." | 3.74 | Central retinal vein occlusion secondary to protein S deficiency. ( Barampouti, F; Yap, YC, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yap, YC | 1 |
| Barampouti, F | 1 |
1 other study available for dalteparin and Hemorrhage, Retinal
| Article | Year |
|---|---|
Central retinal vein occlusion secondary to protein S deficiency.
Topics: Adult; Anticoagulants; Enoxaparin; Follow-Up Studies; Humans; Male; Protein S Deficiency; Retinal He | 2007 |